AbbVie B.V.
Records under this name other than the patents AbbVie B.V. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 3 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,670,220 | Fused Heterocyclic Derivatives as S1P Modulators Formerly held In force · Low confidence | In force | Low confidence | |
| US 9,951,084 | Spiro-Cyclic Amine Derivatives as S1P Modulators Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 10,179,791 | Spiro-Cyclic Amine Derivatives as S1P Modulators Formerly held In force · High confidence | In force | High confidence | |
| US 10,807,991 | Spiro-Cyclic Amine Derivatives as S1P Modulators Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 10,499,357 | Method and System for Transmission of Susi in the NAS Procedure Formerly held In force · High confidence | In force | High confidence | |
| US 7,232,813 | Neutral endopeptidase (NEP) and human soluble endopeptidase (hSEP) inhibitors for prophylaxis and treatment of neuro-degenerative disorders Term ended Term ended Jul 9, 2025 · From the USPTO record | Term ended | Term ended Jul 9, 2025 | From the USPTO record |
| US 9,662,337 | Bisaryl (thio)morpholine derivatives as S1P modulators Lapsed on the fee record Ended May 30, 2025 · From the USPTO record | Lapsed on the fee record | Ended May 30, 2025 | From the USPTO record |
| US 8,138,174 | Compounds with a combination of cannabinoid CB1 antagonism and serotonin reuptake inhibition Lapsed on the fee record Ended Mar 20, 2024 · From the USPTO record | Lapsed on the fee record | Ended Mar 20, 2024 | From the USPTO record |
| US 9,227,960 | Bisaryl (thio)morpholine derivatives as S1P modulators Lapsed on the fee record Ended Jan 5, 2024 · From the USPTO record | Lapsed on the fee record | Ended Jan 5, 2024 | From the USPTO record |
| US 8,084,473 | Heterocyclic compounds with affinity to muscarinic receptors Lapsed on the fee record Ended Dec 27, 2023 · From the USPTO record | Lapsed on the fee record | Ended Dec 27, 2023 | From the USPTO record |